Le Lézard

News by subject: TRI

2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20

11 january 2024

10:25
Endovascular Engineering ("E2"), a medical device company focused on the development and deployment of groundbreaking clot removal technologies that target venous thromboembolism (VTE), announced today FDA Investigational Device Exemption (IDE)...

09:45
New analysis of data published by Susan Halabi, PhD, of Duke University could facilitate approval of new prostate cancer treatments almost two years earlier than the current standard. The study published online January 5, 2024, in the Journal of...

09:00
Scientists have long known that some viruses and bacteria begin infections by latching first onto sugar molecules on the surfaces of cells lining the sinuses and throat of mammals, including humans. Viral particles, for instance, can attach to these...

08:36
The presence of plastics in our oceans and waterbodies is one of the most significant threats to marine ecosystems. In 2022, plastic production exceeded 400 million tons globally, and this number continues to rise. The presence of microplastics,...

08:35
PulseAI, a leader in artificial intelligence healthcare solutions, today announced a significant advancement in consumer device electrocardiogram (ECG) monitoring. Published in the Cardiovascular Digital Health Journal, the new study titled "Reducing...

07:00
Identifai-Genetics, developer of unique AI-based solutions for non-invasive fetal DNA sequencing, announced today that it has launched its first US clinical trial, in collaboration with Columbia University and the Columbia University Irving Medical...

06:00
Neuralace Medical, Inc., an innovator in pain management technology, today proudly announces the FDA clearance of its groundbreaking product, Axon Therapy (mPNS), for the treatment of chronic Painful Diabetic Neuropathy (PDN). This landmark approval...

06:00
GenFleet Therapeutics, a clinical-stage biotechnology company developing cutting-edge therapies in oncology and immunology, announced that U.S. Food and Drug Administration (FDA) has recently granted another two designations for SLS009 (GFH009)....


10 january 2024

14:00
Lykos Therapeutics (formerly MAPS Public Benefit Corporation) ("Lykos"), a company dedicated to transforming mental healthcare, announced that PLOS ONE has published the first comparison of the effects of...

10:44
Chiesi Global Rare Diseases, a business unit of the Chiesi Group established to deliver innovative therapies and solutions for people affected by rare diseases, today announced the publication of data from the Phase 3 BALANCE study that demonstrate...

10:35
PCM Trials, a Denver, USA-based leader in providing mobile research nurses  for decentralized clinical trials (DCTs), today announced the acquisition of Clinical Trial Service (CTS). The Losser, Netherlands-based private clinical research company has...

10:00
3Spine, Inc., a medical device company developing a transformational alternative to lumbar spinal fusion, today announced achievement of US clinical trial enrollment, with 151 completed MOTUS lumbar total joint replacement surgeries and 174...

09:00
Vivalink, a leading provider of digital healthcare solutions, proudly announces significant milestones achieved in 2023, reinforcing its commitment to advancing the adoption of remote patient monitoring in healthcare and clinical trials. The...

08:02
Labcorp, a global leader of innovative and comprehensive laboratory services, and Hawthorne Effect, Inc., a complete clinical trials solution integrating technology, are pleased to announce a strategic collaboration to advance decentralized clinical...

08:01
Upon approval, cabotegravir would be the first injectable, long-acting therapy in Canada for HIV prevention.Application is supported by data from the pivotal phase IIb/III studies evaluating safety and efficacy of long-acting cabotegravir for...

07:05
REGENXBIO Inc. today announced that it will present data from the Phase II AAVIATE® trial of suprachoroidal ABBV-RGX-314 for the treatment of wet age-related macular degeneration (AMD) at Hawaiian Eye and Retina 2024 Meeting being held January...

07:00
A new study, "1,5-Anhydroglucitol: A Novel Biomarker of Adherence in Sodium -Glucose Cotransporter 2 Inhibitors," was published online on December 13, 2023, in Diabetes Care, a journal from the American Diabetes Association. The study was conducted...

06:00
Providence Medical Technology, Inc. (PMT), a medical device innovator focused on improving surgical outcomes for high-risk spine surgery patients, announced that the U.S. Food and Drug Administration (FDA) has cleared its CAVUX® FFS-LX: Lumbar Facet...

05:27
ASG Superconductors' (ASG) MgB2 superconducting technology - already in use for energy and medical applications such as the world's only truly open MROpenEVO magnetic resonance imaging (MRI) system - is at the heart of the worldwide innovation...

03:30
Ariceum Therapeutics, a private biotech company developing radiopharmaceutical products for the diagnosis and treatment of certain hard-to-treat cancers, today announces it has submitted an application with the UK's Medicines and Healthcare products...

02:21
KANAZAWA, Japan, Jan. 10, 2024 /PRNewswire/ -- Researchers at Nano Life Science Institute (WPI-NanoLSI), Kanazawa University report in Nano Letters how the flexibility of a protein hinge plays a crucial role in the transfer of proteins in key cell...

01:52
Guangzhou Fermion Technology Co., Ltd. (Fermion), a clinical-stage AI-based drug discovery company that specializes in developing drugs for autoimmune diseases and pain, has announced today that China National Medical Products Administration (NMPA)...


9 january 2024

14:00
Orrum is proud to announce the first recipient of the Bronze Level Certification in our Center of Excellence (COE) program, HCA Florida Fort Walton-Destin Hospital. This certification is a testament to our dedication to setting high-quality...

11:29
Constant Therapeutics LLC, a biopharmaceutical company focused on the development of treatments impacting the Alternative Renin-Angiotensin System, today announced that the first patient has been dosed in the Company's phase 2 clinical trial of...

10:15
Marius Pharmaceuticals, a pharmaceutical company focused on developing innovative therapies for testosterone deficiency, today announced it has initiated a pilot study to better understand the effect of oral testosterone replacement therapy,...

10:11
Injecting neuroblastoma tumors with Zika virus shrank or eliminated those tumors in studies with mice, suggesting that the virus could someday serve as an effective cancer therapy, according to a study led by Nemours Children's Health researchers and...

09:18
Investors feature leading brain tumor venture philanthropy funds including the Brain Tumor Investment Fund (BTIF) and The Sontag Innovation The along with MEDA Angels, Varia Ventures and private investors.Investment catalyzed by positive results from...

09:15
ConcertAI and Caris Life Sciences (Caris) announced a multi-year partnership to support AbbVie's precision medicine-driven research and development efforts, and...

09:00
Cala, the bioelectronic medicine leader, today announced the results from multiple clinical studies, further strengthening evidence supporting positive outcomes for patients using Cala TAPS Therapy in ET. A randomized pragmatic trial by CVS Health...

08:45
NeuroSense Therapeutics Ltd. ("NeuroSense"), a company developing treatments for severe neurodegenerative diseases, shares a review of important clinical achievements in 2023 and provides a road map for anticipated catalysts in 2024....

08:39
Arkstone Medical Solutions, the leading provider of laboratory infectious disease reporting and proactive antimicrobial stewardship, is excited to embark on a groundbreaking clinical study in collaboration with Laboratorio Clínico Roe in Lima, Peru....

08:00
Today, in honor of Cervical Cancer Awareness Month, Teal Health, a women's health company focused on increasing access to cervical cancer screenings in the US, announces the SELF-CERV clinical study, in progress at leading health organizations...

08:00
Renibus Therapeutics® ("Renibus"), a clinical-stage biopharmaceutical company focusing on the prevention and treatment of cardio, renal and metabolic diseases, today announced publication in...

05:29
Menarini Silicon Biosystems, a pioneer of liquid biopsy technology, announced today the publication, in the Journal of Clinical...

03:43
BioArctic AB's (publ) partner Eisai announced today that Leqembi® (brand name in China: "???", generic name: lecanemab-irmb) has been approved in China as a treatment for mild cognitive impairment (MCI) due to Alzheimer's disease (AD) and mild AD...

03:30
Zedsen Limited is pleased to announce its partnership with leading university hospital, Imperial College Healthcare NHS Trust, in its first clinical research study to validate its technology....

01:00
Chiesi Farmaceutici S.p.A ("Chiesi Group"), an international, research-focused...


8 january 2024

19:00
Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabolic, ophthalmology...

18:30
Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced the U.S. Food and Drug Administration (FDA) issued a complete response letter on January 4, 2024, regarding the Biologics License Application (BLA) for...

18:01
Last Friday, the Department of Veterans Affairs issued a Request for Applications (RFA) to study the use of FDA-designated Breakthrough Therapies, including MDMA-Assisted Therapy and psilocybin, to treat veterans who suffer from PTSD and depression....

13:34
Comprehensive Care Services (CCS) has become the world's largest perfusion provider with the acquisition of German-based Life Systems. This move unites two leaders in perfusion care, expanding global access to top-tier patient services....

11:00
GC Cell, a fully integrated cell therapy pioneer, is proud to announce the approval from both the Australian Human Research Ethics Committee (HREC) and the Korean Ministry of Food and Drug Safety (MFDS) for a Phase 1...

10:33
Dry Eye Disease (DED): PL9643 MELODY-1 Phase 3 StudyData Base Lock 2H January 2024Topline Data Readout Expected Early 1Q Calendar Year 2024Ulcerative Colitis (UC): Oral PL8177 Phase 2 Clinical Study in Active UC PatientsInterim Analysis Data Readout...

09:00
Pulmatrix, Inc. ("Pulmatrix" or the "Company")...

09:00
Suvoda LLC, a global clinical trial technology company that specializes in complex studies in therapeutic areas like oncology, central nervous system (CNS), and rare disease, surpassed 1,400 clinical trials in 2023, and grew sales by 30%...

09:00
Shuttle Pharmaceuticals Holdings, Inc. ("Shuttle Pharma") today announced they have received the 'Safe to Proceed' letter from the U.S. Food and Drug Administration (FDA) for the Company's investigational new drug (IND) application for its Phase II...

08:46
PLT Health Solutions, Inc. announced that Slendacor® Weight Management Complex has added to its intellectual property portfolio with a recently granted patent related to new clinical work that studied mechanisms of action behind its weight loss and...

08:38
Akeso, Inc. (9926.HK) ("Akeso," "we," or the "Company") today announced that Michelle Xia, Ph.D, the founder, chairwoman, president, and CEO of Akeso, will deliver a keynote speech focusing on the Company's achievements in the development of new...

08:30
? Accelerating Innovation and Growth Strategy with Top-Line Data Readouts Expected in 2H 2024 and 2025 from Three Pivotal Phase 3 Studies Evaluating Selinexor in Multiple Myeloma, Endometrial Cancer and Myelofibrosis ?  ? Preliminary Unaudited Full...

08:05
Rigel Pharmaceuticals, Inc.  today provided a business update...

2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20